GenVec
GenVec is a biotechnology company founded in 1992 that developed adenoviral gene-delivery technology, therapeutics and vaccines, including the AdenoVerse platform. Intrexon acquired GenVec in June 2017.
Key facts
| Company Operating Status | Acquired |
|---|---|
| Full Address | 910 Clopper Road, Suite 220N, Gaithersburg, MD 20878, US |
| Public/Private | Public |
| Wellfound ID | genvec |